Our mission is to discover drugs for high unmet medical needs that will improve quality of life for patients with Orphan Diseases.

We stand out by our ability to deliver high value products with relatively little cost in a short period of time. Due to our business model we reduce the risk of drug development.

SOM Biotech has a strong pipeline of products focused on Orphan diseases at preclinical and clinical stages.

NEWS & PRESS RELEASES

SOM Biotech at BIO 2019

SOM Biotech attended the BIO International Convention in Philadelphia last 3-6 June 2019. BIO is […]

Visit our news and press releases archive

GO TO ARCHIVE